DKSC - Dakshidin Corporation, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
-0.0001 (-12.50%)
At close: 10:58AM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
Previous Close0.0006
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0006 - 0.0006
52 Week Range0.0004 - 0.0019
Avg. Volume1,762,968
Market Cap43,749
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for DKSC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Newsfile

    Dakshidin Corporation (DKSC), Signs an Exclusive Distribution Deal with Stenergy LLC

    San Francisco, California--(Newsfile Corp. - October 13, 2022) - Dakshidin Corporation (OTC Pink: DKSC) has signed a distribution deal with one of the market's most exciting manufacturers of all-natural organic supplements.STENERGY LLC offers a product named GluCora™. Stenergy co-founder Sam Butero describes GluCora; "Health Canada has approved GluCora. As a result, we are bringing a product to the market that supports healthy glucose metabolism. In addition, we provide antioxidants for the main